Introduction Despite numerous efforts to describe COVID-19's immunological landscape,
there is still a gap in our understanding of the virus's infections after-effects, especially in the …

The majority of COVID-19 patients experience mild to moderate disease course and recover
within a few weeks. An increasing number of studies characterized the long-term changes in …

Host immune responses play central roles in controlling SARS-CoV2 infection, yet remain
incompletely characterized and understood. Here, we present a comprehensive immune …

A dysfunctional immune response in coronavirus disease 2019 (COVID-19) patients is a
recurrent theme impacting symptoms and mortality, yet a detailed understanding of pertinent …

Since 2019, the coronavirus (COVID-19) has outbroken continuously, spreading
internationally and threatening the public health. However, it was unknown how the disorder …

The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection
remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that …

Clinical heterogeneity and varied prognosis are well noted for SARS-CoV-2 infection.
Altered immune response is a major feature for the adverse prognosis however focus on …

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection is a global crisis; however, our current …

The outbreak of coronavirus disease 2019 (COVID-19) caused by the new virus SARS-CoV-
2 has been announced as a public health emergency of international concern. 1-3 The …

Despite many studies on the immune characteristics of Coronavirus disease 2019 (COVID-
19) patients in the progression stage, a detailed understanding of pertinent immune cells in …